Curaleaf Holdings (CURLF) Goodwill & Intangibles (2019 - 2025)
Curaleaf Holdings (CURLF) posted quarterly Goodwill & Intangibles of $1.6 billion for Q4 2025, down 3.97% year-on-year from $1.7 billion in Q4 2024, and down 3.97% on a QoQ basis from $1.7 billion in Q4 2024.
Curaleaf Holdings (CURLF) Goodwill & Intangibles (2019 - 2025) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Goodwill & Intangibles for 7 consecutive years, with $1.6 billion the latest figure, recorded in Q4 2025.
- Quarterly Goodwill & Intangibles fell 3.97% year-over-year to $1.6 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 billion (down 3.97% YoY) and the FY2025 annual result came in at $1.6 billion, down 3.97% from the prior year.
- Goodwill & Intangibles declined to $1.6 billion in Q4 2025 per CURLF's latest filing, from $1.7 billion in the prior quarter.
- Over the last five years, Goodwill & Intangibles for CURLF reached as high as $1840.8 billion in Q1 2022 and fell as low as -$14.6 million in Q4 2021.
- A 5-year average of $124.2 billion and a median of $1.8 billion in 2024 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2022 — Goodwill & Intangibles soared 147053.92% — and 2024, when it fell 6.73%.
- Year by year, Goodwill & Intangibles stood at -$14.6 million in 2021, then soared by 12715.33% to $1.8 billion in 2022, then retreated by 2.14% to $1.8 billion in 2023, then dropped by 4.71% to $1.7 billion in 2024, then dropped by 3.97% to $1.6 billion in 2025.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $1.6 billion, $1.7 billion, and $1.8 billion for Q4 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.65 Bn |
| Dec 31, 2024 | 1.71 Bn |
| Sep 30, 2024 | 1.76 Bn |
| Jun 30, 2024 | 1.77 Bn |
| Dec 31, 2023 | 1.80 Bn |
| Sep 30, 2023 | 1.86 Bn |
| Jun 30, 2023 | 1.90 Bn |
| Dec 31, 2022 | 1.84 Bn |
| Sep 30, 2022 | 1.83 Bn |
| Jun 30, 2022 | 1.82 Bn |
| Mar 31, 2022 | 1,840.82 Bn |
| Dec 31, 2021 | -14.57 Mn |
| Sep 30, 2021 | 1.63 Bn |
| Jun 30, 2021 | 1.70 Bn |
| Mar 31, 2021 | 1.25 Bn |
| Dec 31, 2020 | -23.66 Mn |
| Sep 30, 2020 | 1.25 Bn |
| Dec 31, 2019 | 254.96 Mn |